Share-based Payment Arrangement, Expense in USD of HELIUS MEDICAL TECHNOLOGIES, INC. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
HELIUS MEDICAL TECHNOLOGIES, INC. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2015 to Q3 2025.
  • HELIUS MEDICAL TECHNOLOGIES, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $472K, a 64.4% decline year-over-year.
  • HELIUS MEDICAL TECHNOLOGIES, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $1.93M, a 22.6% decline year-over-year.
  • HELIUS MEDICAL TECHNOLOGIES, INC. annual Share-based Payment Arrangement, Expense for 2024 was $2.52M, a 54.8% increase from 2023.
  • HELIUS MEDICAL TECHNOLOGIES, INC. annual Share-based Payment Arrangement, Expense for 2023 was $1.63M, a 27.7% decline from 2022.
  • HELIUS MEDICAL TECHNOLOGIES, INC. annual Share-based Payment Arrangement, Expense for 2022 was $2.25M, a 47% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

HELIUS MEDICAL TECHNOLOGIES, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.93M $472K -$855K -64.4% 01 Jul 2025 30 Sep 2025 10-Q 18 Nov 2025
Q2 2025 $2.79M $410K +$43K +11.7% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $2.74M $622K +$221K +55.1% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025
Q4 2024 $2.52M $427K +$26K +6.48% 01 Oct 2024 31 Dec 2024 10-K 25 Mar 2025
Q3 2024 $2.5M $1.33M +$924K +229% 01 Jul 2024 30 Sep 2024 10-Q 18 Nov 2025
Q2 2024 $1.57M $367K -$53K -12.6% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $1.63M $401K -$4K -0.99% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025
Q4 2023 $1.63M $401K +$169K +72.8% 01 Oct 2023 31 Dec 2023 10-K 25 Mar 2025
Q3 2023 $1.46M $403K -$1.04M -72% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $2.5M $420K +$241K +135% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $2.26M $405K +$3K +0.75% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $2.25M $232K -$124K -34.8% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $2.38M $1.44M +$701K +94.7% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $1.68M $179K -$2.45M -93.2% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $4.13M $402K -$125K -23.7% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $4.25M $356K -$152K -29.9% 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023
Q3 2021 $4.4M $740K +$290K +64.4% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $4.11M $2.63M +$1.9M +261% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $2.21M $527K -$315K -37.4% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $2.53M $508K -$847K -62.5% 01 Oct 2020 31 Dec 2020 10-K 14 Mar 2022
Q3 2020 $3.38M $450K -$1.11M -71.2% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $4.49M $729K -$212K -22.5% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $4.7M $842K +$7K +0.84% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021
Q4 2019 $4.69M $1.36M +$505K +59.4% 01 Oct 2019 31 Dec 2019 10-K 10 Mar 2021
Q3 2019 $4.19M $1.56M +$1.04M +197% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $3.15M $941K -$5.39M -85.1% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 $8.54M $835K +$448K +116% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 $8.1M $850K +$496K +140% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 $7.6M $525K -$149K -22.1% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $7.75M $6.33M +$5.79M +1056% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 $1.96M $387K +$145K +59.9% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 $1.82M $354K 01 Oct 2017 31 Dec 2017 10-K 14 Mar 2019
Q3 2017 $674K +$26K +4.01% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 $548K +$271K +97.8% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 $242K -$557K -69.7% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q3 2016 $648K 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 $277K 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 $799K 01 Jan 2016 31 Mar 2016 10-Q 16 May 2017

HELIUS MEDICAL TECHNOLOGIES, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $2.52M +$893K +54.8% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025
2023 $1.63M -$625K -27.7% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025
2022 $2.25M -$2M -47% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $4.25M +$1.72M +68.1% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023
2020 $2.53M -$2.16M -46.1% 01 Jan 2020 31 Dec 2020 10-K 14 Mar 2022
2019 $4.69M -$3.4M -42.1% 01 Jan 2019 31 Dec 2019 10-K 10 Mar 2021
2018 $8.1M +$6.28M +345% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020
2017 $1.82M 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019
2015 $1.23M 01 Apr 2015 31 Mar 2016 10-KT 03 Apr 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.